Carboplatin News and Research

RSS
Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers).
Study finds biochemical pathway that triggers regrowth of breast cancer stem cells after chemotherapy

Study finds biochemical pathway that triggers regrowth of breast cancer stem cells after chemotherapy

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

I-SPY2 research initiative employs exciting new model for testing breast cancer drugs

I-SPY2 research initiative employs exciting new model for testing breast cancer drugs

First-line nivolumab promising in advanced NSCLC

First-line nivolumab promising in advanced NSCLC

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Drug candidate delivered by plant-virus-based carrier shows promise for triple-negative breast cancer

Drug candidate delivered by plant-virus-based carrier shows promise for triple-negative breast cancer

Novel drug atezolizumab harnesses immune system to shrink tumors in advanced bladder cancer

Novel drug atezolizumab harnesses immune system to shrink tumors in advanced bladder cancer

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

Researchers find new clue to understanding 'chemo brain' in cancer patients

Researchers find new clue to understanding 'chemo brain' in cancer patients

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Survivin inhibitor with chemotherapy provides therapeutic advantage for Rb cells, tumors

Survivin inhibitor with chemotherapy provides therapeutic advantage for Rb cells, tumors

Added benefit of crizotinib drug for first-line treatment of advanced bronchial carcinoma not proven

Added benefit of crizotinib drug for first-line treatment of advanced bronchial carcinoma not proven

Research unveils standard front-line treatment for advanced ovarian cancer

Research unveils standard front-line treatment for advanced ovarian cancer

TSRI scientists reveal workings of key 'relief-valve' in cells

TSRI scientists reveal workings of key 'relief-valve' in cells

OncoGenex provides update on Phase 2 Spruce trial in patients with untreated metastatic NSCLC

OncoGenex provides update on Phase 2 Spruce trial in patients with untreated metastatic NSCLC

Pathologic complete response after presurgery chemotherapy increases overall survival for TNBC patients

Pathologic complete response after presurgery chemotherapy increases overall survival for TNBC patients

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

Researchers pinpoint mechanisms that cause chemoresistance in ovarian cancer patients

Researchers pinpoint mechanisms that cause chemoresistance in ovarian cancer patients

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer